Clinical trials of first TB vaccine from human source begins in India – Pharma News
MTBVAC, the Spanish tuberculosis vaccine which is the first live attenuated vaccine of Mycobacterium tuberculosis isolated from a human, will undergo clinical trials in India. According to the company’s press statement, the trials are carried out by Bharat Biotech in close collaboration with Biofabri. Trials to evaluate the safety and immunogenicity of MTBVAC have started …